Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway

被引:105
作者
Feng, WJ
Webb, P
Nguyen, P
Liu, XH
Li, JD
Karin, M
Kushner, PJ [1 ]
机构
[1] Univ Calif San Francisco, Metab Res Unit 1119 HSW, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
关键词
D O I
10.1210/me.15.1.32
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen receptor (ER) is activated either by ligand or by signals from tyrosine kinase-linked cell surface receptors. We investigated whether the nonreceptor Src tyrosine kinase could affect 88 activity. Expression of constitutively active Src or stimulation of the endogenous Src/JNK pathway enhances transcriptional activation by the estrogen-ER complex and strongly stimulates the otherwise weak activation by the unliganded ER and the tamoxifen-ER complex. Src affects ER activation function 1 (AF-1), and not ER AF-2, and does so through its tyrosine kinase activity. This effect of Src is mediated partly through a Raf/mitogen-activated ERK kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) signaling cascade and partly through a MEKK/JNKK/JNK cascade. Although, as previously shown, Src action through activated ERK stimulates AF-1 by phosphorylation at S118, Src action through activated JNK neither leads to phosphorylation of S118 nor requires S118 for its action. We therefore suggest that the Src/JNK pathway enhances AF-1 activity by modification of ER AF-1-associated proteins. Src potentiates activation functions in CREB-binding protein (CBP) and glucocorticoid receptor interacting protein 1 (GRIP1), and we discuss the possibility that the Src/JNK pathway enhances the activity of these coactivators, which are known to mediate AF-1 action.
引用
收藏
页码:32 / 45
页数:14
相关论文
共 88 条
[21]  
EL TM, 1997, MOL ENDOCRINOL, V11, P928
[22]  
Endoh H, 1999, MOL CELL BIOL, V19, P5363
[23]   Nuclear receptor coactivators [J].
Glass, CK ;
Rose, DW ;
Rosenfeld, MG .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :222-232
[24]   p300 is a component of an estrogen receptor coactivator complex [J].
Hanstein, B ;
Eckner, R ;
DiRenzo, J ;
Halachmi, S ;
Liu, H ;
Searcy, B ;
Kurokawa, R ;
Brown, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11540-11545
[25]   A signature motif in transcriptional co-activators mediates binding to nuclear receptor [J].
Heery, DM ;
Kalkhoven, E ;
Hoare, S ;
Parker, MG .
NATURE, 1997, 387 (6634) :733-736
[26]   IDENTIFICATION OF AN ONCOPROTEIN-RESPONSIVE AND UV-RESPONSIVE PROTEIN-KINASE THAT BINDS AND POTENTIATES THE C-JUN ACTIVATION DOMAIN [J].
HIBI, M ;
LIN, AN ;
SMEAL, T ;
MINDEN, A ;
KARIN, M .
GENES & DEVELOPMENT, 1993, 7 (11) :2135-2148
[27]   POTENT INHIBITION OF BREAST-CANCER CELL-LINES BY THE ISOFLAVONOID KIEVITONE - COMPARISON WITH GENISTEIN [J].
HOFFMAN, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (02) :600-606
[28]   GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors [J].
Hong, H ;
Kohli, K ;
Trivedi, A ;
Johnson, DL ;
Stallcup, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) :4948-4952
[29]   GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors [J].
Hong, H ;
Kohli, K ;
Garabedian, MJ ;
Stallcup, MR .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (05) :2735-2744
[30]   CROSS-TALK BETWEEN PEPTIDE GROWTH-FACTOR AND ESTROGEN-RECEPTOR SIGNALING SYSTEMS [J].
IGNARTROWBRIDGE, DM ;
PIMENTEL, M ;
TENG, CT ;
KORACH, KS ;
MCLACHLAN, JA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 :35-38